...
首页> 外文期刊>Expert review of respiratory medicine >Platelet activating factor receptor: gateway for bacterial chronic airway infection in chronic obstructive pulmonary disease and potential therapeutic target
【24h】

Platelet activating factor receptor: gateway for bacterial chronic airway infection in chronic obstructive pulmonary disease and potential therapeutic target

机译:血小板活化因子受体:慢性阻塞性肺疾病中细菌性慢性气道感染的途径和潜在的治疗靶标

获取原文
获取原文并翻译 | 示例

摘要

The authors established that cigarette smoke increases airway epithelial platelet activating factor receptor (PAFr) expression and that PAFr is markedly up-regulated in the lungs of chronic obstructive pulmonary disease (COPD) patients. Crucially, PAFr is used by the two key bacterial species involved in chronic infection and acute exacerbations in COPD, that is, Streptococcus pneumoniae and Haemophilus influenzae, as a receptor for lung epithelial colonization. The cognate adhesin of PAFr, phosphorylcholine (ChoP), in the cell wall of these bacterial species may be a key effector that underpins host colonization. In this review, the authors evaluate the respective roles of PAFr and ChoP in the natural history of COPD and discuss the potential of the airway epithelial PAFr-bacterial ChoP interaction as a selective anti-infective target in COPD therapeutics.
机译:作者证实,香烟烟雾会增加气道上皮血小板活化因子受体(PAFr)的表达,并且慢性阻塞性肺疾病(COPD)患者的肺中PAFr明显上调。至关重要的是,参与慢性阻塞性肺病慢性感染和急性加重的两种关键细菌,即肺炎链球菌和流感嗜血杆菌,都将PAFr用作肺上皮定植的受体。在这些细菌物种的细胞壁中,PAFr的同源粘附素磷酸胆碱(ChoP)可能是支撑宿主定殖的关键效应子。在这篇综述中,作者评估了PAFr和ChoP在COPD自然史中的各自作用,并讨论了气道上皮PAFr-细菌ChoP相互作用作为COPD治疗中选择性抗感染靶标的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号